Publications by authors named "Inga Buchmann"

Claim this Profile
R
Resection of Non-Functional Pancreatic Neuroendocrine Neoplasms-A Single-Center Retrospective Outcome Analysis.
Kirsten Lindner, Daniel Binte, Jens Hoeppner, Ulrich F Wellner, Dominik M Schulte, Inga Buchmann

Curr Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Joint DGN, OGNMB and SGNM S1 guideline for radiosynoviorthesis].
Michael Gabriel, Thorsten D Pöppel, Lutz S Freudenberg, Jamshid Farahati, Thomas Krause, Inga Buchmann

Nuklearmedizin· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PET/CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma.
Ingo Janssen, Clara C Chen, Corina M Millo, Alexander Ling, David Taieb, Inga Buchmann

Eur J Nucl Med Mol Imaging· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
68Ga-DOTATATE PET/CT in the Localization of Head and Neck Paragangliomas Compared with Other Functional Imaging Modalities and CT/MRI.
Ingo Janssen, Clara C Chen, David Taieb, Nicholas J Patronas, Corina M Millo, Inga Buchmann

J Nucl Med· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recessively inherited parkinsonism: effect of ATP13A2 mutations on the clinical and neuroimaging phenotype.
Norbert Brüggemann, Johann Hagenah, Kathrin Reetz, Alexander Schmidt, Meike Kasten, Inga Buchmann

Arch Neurol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiolabeled cetuximab plus whole-brain irradiation (WBI) for the treatment of brain metastases from non-small cell lung cancer (NSCLC).
Dirk Rades, Roger Nadrowitz, Inga Buchmann, Peter Hunold, Frank Noack

Strahlenther Onkol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High 2-[18F]fluoro-2-deoxy-d-glucose (18FDG) uptake measured by positron emission tomography is associated with reduced overall survival in patients with oral squamous cell carcinoma.
Christof Hofele, Kolja Freier, Oliver C Thiele, Uwe Haberkorn, Inga Buchmann

Oral Oncol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloablative radioimmunotherapy in conditioning prior to haematological stem cell transplantation: closing the gap between benefit and toxicity?
Inga Buchmann, Ralf G Meyer, Walter Mier, Uwe Haberkorn

Eur J Nucl Med Mol Imaging· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of cell proportions and proliferation rates on FDG uptake in squamous-cell esophageal carcinoma: a PET study.
Inga Buchmann, Uwe Haberkorn, Irene Schmidtmann, Christoph Brochhausen, Hans-Georg Buchholz

Cancer Biother Radiopharm· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of 99mtechnetium-pertechnetate and 123iodide SPECT with FDG-PET in patients suspicious for breast cancer.
Inga Buchmann, Karen Riedmüller, Simone Hoffner, Ulrich Mack, Sebastian Aulmann

Cancer Biother Radiopharm· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiolabeled peptides and proteins in cancer therapy.
Carmen Wängler, Inga Buchmann, Michael Eisenhut, Uwe Haberkorn, Walter Mier

Protein Pept Lett· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone marrow transplantation nephropathy after an intensified conditioning regimen with radioimmunotherapy and allogeneic stem cell transplantation.
Thorsten Zenz, Richard F Schlenk, Gerhard Glatting, Bernd Neumaier, Norbert Blumstein, Inga Buchmann

J Nucl Med· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted marrow irradiation with radioactively labeled anti-CD66 monoclonal antibody prior to allogeneic stem cell transplantation for patients with leukemia: results of a phase I-II study.
Thorsten Zenz, Gerhard Glatting, Richard F Schlenk, Inga Buchmann, Hartmut Döhner

Haematologica· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
188Re or 90Y-labelled anti-CD66 antibody as part of a dose-reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I-II study.
Mark Ringhoffer, Norbert Blumstein, Bernd Neumaier, Gerhard Glatting, Stephanie von Harsdorf, Inga Buchmann

Br J Haematol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[18F]3'-deoxy-3'-fluorothymidine-PET in NHL patients: whole-body biodistribution and imaging of lymphoma manifestations--a pilot study.
Inga Buchmann, Bernd Neumaier, Mathias Schreckenberger, Sven Reske

Cancer Biother Radiopharm· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beta-irradiation used for systemic radioimmunotherapy induces apoptosis and activates apoptosis pathways in leukaemia cells.
Claudia Friesen, Annelie Lubatschofski, Jörg Kotzerke, Inga Buchmann, Sven N Reske

Eur J Nucl Med Mol Imaging· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDG PET for imaging pericardial manifestations of Hodgkin lymphoma.
Inga Buchmann, Hannes Wandt, Andreas Wahl, Sven Norbert Reske

Clin Nucl Med· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[18F]5-fluoro-2-deoxyuridine-PET for imaging of malignant tumors and for measuring tissue proliferation.
Inga Buchmann, Andreas T J Vogg, Gerhard Glatting, Stefan Schultheiss, Peter Möller

Cancer Biother Radiopharm· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of the biodistribution and biokinetics of (99m)Tc-anti-CD66 mAb BW 250/183 and (99m)Tc-anti-CD45 mAb YTH 24.5 with regard to suitability for myeloablative radioimmunotherapy.
Inga Buchmann, Thomas Kull, Gerhard Glatting, Donald Bunjes, Geoffrey Hale

Eur J Nucl Med Mol Imaging· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloablative radioimmunotherapy with Re-188-anti-CD66-antibody for conditioning of high-risk leukemia patients prior to stem cell transplantation: biodistribution, biokinetics and immediate toxicities.
Inga Buchmann, Donald Bunjes, Jörg Kotzerke, Hans Martin, Gerhard Glatting

Cancer Biother Radiopharm· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis